Get the Stockscreener App
3.35
4.04%
0.13
After Hours:
3.35
Leap Therapeutics Inc Stock (LPTX) Forecast
The Leap Therapeutics Inc (LPTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.8486, representing a +14.88% increase from the current price of $3.35. The highest analyst price target is $4.3444, and the lowest is $3.3529.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LPTX Price Target
Average 4.0687
(+21.45% Upside)
Is Leap Therapeutics Inc (LPTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 61.06 | Neutral |
| STOCH(9,6) | 65.72 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.0269 | Buy |
| ADX(14) | 12.99 | Neutral |
| William %R | -1.5625 | Sell |
| CCI(14) | 177.13 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.9785
Buy
|
3.0527
Buy
|
| MA20 |
3.0403
Buy
|
3.019
Buy
|
| MA50 |
3.1397
Buy
|
2.984
Buy
|
| MA100 |
2.9038
Buy
|
2.8811
Buy
|
| MA200 |
2.684
Buy
|
2.7295
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, LPTX could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 2 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on LPTX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 61.06 indicates that LPTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 65.72 indicates that LPTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that LPTX is oversold. This suggests that LPTX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 12.99 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 177.13 indicates that LPTX is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term LPTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Leap Therapeutics Inc financial reports and earnings history, Leap Therapeutics Inc (LPTX) stock could reach $4.9729 by 2030, $9.3475 by 2040 and $15.03 by 2050. See the projected annual prices until 2050 of the Leap Therapeutics Inc stock below:
- Leap Therapeutics Inc (LPTX) is expected to reach an average price of $8.806 in 2035, with a high prediction of $9.361 and a low estimate of $7.6481. This indicates an $162.87% rise from the last recorded price of $3.35.
- Leap Therapeutics Inc (LPTX) stock is projected to chart a bullish course in 2040, with an average price target of $9.3198, representing an $178.20% surge from its current level. The forecast ranges from a conservative $9.187 to a sky-high $9.3475.
- Our analysts predict Leap Therapeutics Inc (LPTX) to jump 258.24% by 2045, soaring from $11.98 to an average price of $12.00, potentially reaching $12.69. While $11.98 is the low estimate, the potential upside is significant.
- Leap Therapeutics Inc (LPTX) stock is expected to climb by 2050, reaching an average of $14.80, a $341.92% jump from its current level. However, a wide range of estimates exists, with high and low targets of $15.03 and $14.49, respectively, highlighting the market's uncertainty.
Leap Therapeutics Inc Stock (LPTX) Year by Year Forecast
Leap Therapeutics Inc Stock (LPTX) Price Forecast for 2025
Leap Therapeutics Inc Stock (LPTX) is expected to reach an average price of $3.8384 in 2025, with a high prediction of $5.0572 and a low estimate of $2.6195. This indicates an +14.58% rise from the last recorded price of $3.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $3.8001 | $3.3529 | $4.3444 | +13.44% |
| March, 2025 | $4.3629 | $3.6958 | $5.0572 | +30.24% |
| April, 2025 | $3.5215 | $3.0801 | $4.8787 | +5.12% |
| May, 2025 | $3.6844 | $3.2672 | $3.9187 | +9.98% |
| June, 2025 | $4.2773 | $3.9815 | $4.5501 | +27.68% |
| July, 2025 | $4.0708 | $3.9887 | $5.0244 | +21.52% |
| August, 2025 | $3.9987 | $3.9587 | $4.3316 | +19.36% |
| September, 2025 | $3.9516 | $3.7944 | $4.3201 | +17.96% |
| October, 2025 | $3.9401 | $3.7644 | $4.093 | +17.62% |
| November, 2025 | $4.093 | $3.8673 | $4.2059 | +22.18% |
| December, 2025 | $4.0916 | $4.0216 | $4.5259 | +22.14% |
Leap Therapeutics Inc Stock (LPTX) Price Forecast for 2026
The predicted value for Leap Therapeutics Inc (LPTX) in 2026 is set at an average of $5.1016. Estimates vary from a peak of $6.6088 to a trough of $3.5945, indicating an +52.29% surge from the present price of $3.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.7545 | $3.5945 | $4.4273 | +12.07% |
| February, 2026 | $4.2923 | $3.7359 | $4.3273 | +28.13% |
| March, 2026 | $4.4202 | $4.2238 | $4.773 | +31.95% |
| April, 2026 | $5.0888 | $4.4116 | $5.473 | +51.90% |
| May, 2026 | $4.7216 | $4.0502 | $5.1838 | +40.94% |
| June, 2026 | $4.0845 | $4.0031 | $5.1173 | +21.93% |
| July, 2026 | $3.8831 | $3.7459 | $4.2102 | +15.91% |
| August, 2026 | $4.1359 | $3.8588 | $4.2499 | +23.46% |
| September, 2026 | $3.9145 | $3.8095 | $4.2317 | +16.85% |
| October, 2026 | $3.9674 | $3.706 | $4.1574 | +18.43% |
| November, 2026 | $4.1303 | $3.9531 | $4.2795 | +23.29% |
| December, 2026 | $6.4338 | $3.8117 | $6.6088 | +92.05% |
Leap Therapeutics Inc Stock (LPTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Leap Therapeutics Inc (LPTX) is $5.0524, with a high forecast of $6.5345 and a low forecast of $3.5703. This indicates an +50.82% increase from the last price of $3.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.3717 | $5.2317 | $6.5345 | +60.35% |
| February, 2027 | $4.7546 | $4.7346 | $5.4274 | +41.93% |
| March, 2027 | $5.2231 | $4.5003 | $5.3731 | +55.91% |
| April, 2027 | $5.376 | $5.1489 | $5.9793 | +60.48% |
| May, 2027 | $4.5489 | $4.1974 | $5.6517 | +35.79% |
| June, 2027 | $4.3975 | $4.326 | $5.1346 | +31.27% |
| July, 2027 | $4.3603 | $4.1142 | $4.5346 | +30.16% |
| August, 2027 | $4.1032 | $4.0432 | $4.5717 | +22.48% |
| September, 2027 | $3.7718 | $3.5703 | $4.1752 | +12.59% |
| October, 2027 | $3.6946 | $3.6079 | $3.8789 | +10.29% |
| November, 2027 | $4.0475 | $3.7203 | $4.0911 | +20.82% |
| December, 2027 | $4.0261 | $3.7546 | $4.1461 | +20.18% |
Leap Therapeutics Inc Stock (LPTX) Price Forecast for 2028
In 2028, Leap Therapeutics Inc (LPTX) is projected to reach an average price of $5.7154, with a high projection of $8.2076 and a low estimate of $3.2233. This indicates an +70.61% rise from the last price of $3.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.2489 | $3.979 | $4.4475 | +26.83% |
| February, 2028 | $3.6618 | $3.6318 | $4.6247 | +9.31% |
| March, 2028 | $3.6614 | $3.6242 | $3.739 | +9.30% |
| April, 2028 | $3.4195 | $3.3718 | $3.6861 | +2.08% |
| May, 2028 | $3.3318 | $3.2818 | $3.4797 | -0.54% |
| June, 2028 | $3.6038 | $3.2675 | $3.6725 | +7.58% |
| July, 2028 | $3.5077 | $3.4881 | $3.6404 | +4.71% |
| August, 2028 | $3.4061 | $3.3272 | $3.5773 | +1.68% |
| September, 2028 | $3.269 | $3.2233 | $3.4419 | -2.42% |
| October, 2028 | $3.3708 | $3.2647 | $3.4019 | +0.62% |
| November, 2028 | $3.8904 | $3.3686 | $4.0304 | +16.13% |
| December, 2028 | $6.1633 | $3.5376 | $8.2076 | +83.98% |
Leap Therapeutics Inc Stock (LPTX) Price Forecast for 2029
The 2029 price forecast for Leap Therapeutics Inc Stock (LPTX) is $6.2851 on average, with a high prediction of $8.2105 and a low estimate of $4.3598. This represents an +87.62% increase from the previous price of $3.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.8019 | $5.3162 | $6.7947 | +73.19% |
| February, 2029 | $5.2048 | $5.1048 | $5.8376 | +55.37% |
| March, 2029 | $4.6776 | $4.6176 | $5.5205 | +39.63% |
| April, 2029 | $4.6505 | $4.3598 | $5.0557 | +38.82% |
| May, 2029 | $4.5391 | $4.453 | $5.0391 | +35.49% |
| June, 2029 | $5.5219 | $4.4848 | $6.1905 | +64.83% |
| July, 2029 | $7.3498 | $5.5577 | $8.0248 | +119.40% |
| August, 2029 | $6.2334 | $5.4377 | $8.2105 | +86.07% |
| September, 2029 | $6.2262 | $6.0891 | $6.9548 | +85.86% |
| October, 2029 | $5.8048 | $5.4098 | $6.452 | +73.28% |
| November, 2029 | $6.1077 | $5.6117 | $7.692 | +82.32% |
| December, 2029 | $4.92 | $4.91 | $6.719 | +46.87% |
Leap Therapeutics Inc Stock (LPTX) Price Forecast for 2030
Leap Therapeutics Inc Stock (LPTX) is expected to reach an average price of $5.6037 in 2030, with a high forecast of $6.9645 and a low forecast of $4.243. This signifies an +67.28% surge from the last price of $3.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.8972 | $4.6957 | $4.9729 | +46.18% |
| February, 2030 | $5.4179 | $4.8429 | $5.5529 | +61.73% |
| March, 2030 | $5.7486 | $5.2593 | $5.8372 | +71.60% |
| April, 2030 | $5.0143 | $4.8415 | $5.7501 | +49.68% |
| May, 2030 | $4.7015 | $4.6415 | $5.3886 | +40.34% |
| June, 2030 | $4.7072 | $4.6729 | $4.8458 | +40.51% |
| July, 2030 | $4.3484 | $4.243 | $5.0515 | +29.80% |
| August, 2030 | $4.6085 | $4.3458 | $4.6101 | +37.57% |
| September, 2030 | $5.5499 | $4.5911 | $5.7959 | +65.67% |
| October, 2030 | $5.9528 | $5.2773 | $6.2287 | +77.70% |
| November, 2030 | $5.3288 | $5.2388 | $6.9645 | +59.07% |
| December, 2030 | $5.3095 | $5.0102 | $5.5716 | +58.49% |
0.60%
2.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):